• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.CXCR3 配体与弥漫性肺泡损伤到慢性肺移植功能障碍的连续体有关。
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1117-25. doi: 10.1164/rccm.201305-0861OC.
2
The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.在肺移植后,机化性肺炎期间CXCR3趋化因子对慢性肺移植功能障碍风险的预后重要性。
PLoS One. 2017 Jul 7;12(7):e0180281. doi: 10.1371/journal.pone.0180281. eCollection 2017.
3
Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.肺移植术后同种异体移植物损伤起始时间对慢性肺同种异体移植物功能障碍发展的影响。
Am J Transplant. 2017 May;17(5):1294-1303. doi: 10.1111/ajt.14066. Epub 2016 Oct 31.
4
The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.支气管肺泡灌洗液 CXCL9 在微小急性排斥反应期间对慢性肺移植功能障碍风险的预后意义。
Am J Transplant. 2018 Jan;18(1):136-144. doi: 10.1111/ajt.14397. Epub 2017 Aug 2.
5
Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.移植后损伤时的血浆 CXCL9 和 CXCL10 可预测慢性肺移植功能障碍。
Am J Transplant. 2022 Sep;22(9):2169-2179. doi: 10.1111/ajt.17108. Epub 2022 Jun 15.
6
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.CXCL9/CXCR3趋化因子生物学在急性肺移植排斥反应发病机制中的作用
J Immunol. 2003 Nov 1;171(9):4844-52. doi: 10.4049/jimmunol.171.9.4844.
7
Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.CXCR3趋化因子生物学在闭塞性细支气管炎综合征发病机制中的关键作用。
J Immunol. 2002 Jul 15;169(2):1037-49. doi: 10.4049/jimmunol.169.2.1037.
8
Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.探讨肺移植后弥漫性肺泡损伤的病理发现。
J Heart Lung Transplant. 2012 Apr;31(4):354-63. doi: 10.1016/j.healun.2011.12.015. Epub 2012 Feb 11.
9
Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.基于支气管肺泡灌洗细胞因子的临床稳定肺移植受者最小急性排斥反应风险分层
J Heart Lung Transplant. 2021 Dec;40(12):1540-1549. doi: 10.1016/j.healun.2021.05.017. Epub 2021 May 29.
10
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.趋化因子受体3(Cxcr3)及其配体CXCL10由浸润肺移植体的炎性细胞表达,并在排斥反应部位介导T细胞的趋化作用。
Am J Pathol. 2001 May;158(5):1703-11. doi: 10.1016/S0002-9440(10)64126-0.

引用本文的文献

1
Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study.可能的慢性肺移植功能障碍的预后与风险:一项前瞻性多中心研究
Am J Respir Crit Care Med. 2025 Feb;211(2):239-247. doi: 10.1164/rccm.202403-0568OC.
2
Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists.诊断一致性优化肺移植病理学家之间的评分者间可靠性。
J Heart Lung Transplant. 2025 Feb;44(2):173-181. doi: 10.1016/j.healun.2024.10.007. Epub 2024 Oct 13.
3
BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.支气管肺泡灌洗液嗜酸性粒细胞增多与慢性肺移植功能障碍风险相关:一项多中心研究。
Chest. 2023 Sep;164(3):670-681. doi: 10.1016/j.chest.2023.03.033. Epub 2023 Mar 30.
4
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.肺移植后急性肺损伤和机化性肺炎的预后影响及临床危险因素:一项多中心前瞻性队列研究的数据
Am J Transplant. 2022 Dec;22(12):3002-3011. doi: 10.1111/ajt.17183. Epub 2022 Sep 12.
5
Why Cell-Free DNA Can Be a "Game Changer" for Lung Allograft Monitoring for Rejection and Infection.为何游离DNA可成为肺移植排斥和感染监测的“变革者”。
Curr Pulmonol Rep. 2022;11(3):75-85. doi: 10.1007/s13665-022-00292-8. Epub 2022 Jul 26.
6
Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.移植后损伤时的血浆 CXCL9 和 CXCL10 可预测慢性肺移植功能障碍。
Am J Transplant. 2022 Sep;22(9):2169-2179. doi: 10.1111/ajt.17108. Epub 2022 Jun 15.
7
Effector immune cells in chronic lung allograft dysfunction: A systematic review.慢性肺移植功能障碍中的效应免疫细胞:一项系统综述。
Immunology. 2022 May;166(1):17-37. doi: 10.1111/imm.13458. Epub 2022 Mar 1.
8
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.同种异体移植损伤标志物 CXCL9 可预测肺移植后抗 HLA 抗体的预后。
Am J Transplant. 2022 Feb;22(2):565-573. doi: 10.1111/ajt.16827. Epub 2021 Nov 12.
9
A flexible joint model for multiple longitudinal biomarkers and a time-to-event outcome: With applications to dynamic prediction using highly correlated biomarkers.一种用于多个纵向生物标志物和事件时间结局的灵活联合模型:在使用高度相关生物标志物进行动态预测中的应用。
Biom J. 2021 Dec;63(8):1575-1586. doi: 10.1002/bimj.202000085. Epub 2021 Jul 17.
10
Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation.低剂量鲁索替尼挽救治疗可显著改善异基因造血干细胞移植后慢性移植物抗宿主病患者的闭塞性细支气管炎综合征。
Front Pharmacol. 2021 Jun 28;12:668825. doi: 10.3389/fphar.2021.668825. eCollection 2021.

本文引用的文献

1
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.闭塞性细支气管炎综合征:肺移植的阿喀琉斯之踵。
Semin Respir Crit Care Med. 2013 Jun;34(3):336-51. doi: 10.1055/s-0033-1348467. Epub 2013 Jul 2.
2
Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.肺移植后人类白细胞抗原抗体的意义:441 例患者 10 年的经验。
Chest. 2013 Jul;144(1):226-233. doi: 10.1378/chest.12-0587.
3
Progression pattern of restrictive allograft syndrome after lung transplantation.肺移植后限制性移植物综合征的进展模式。
J Heart Lung Transplant. 2013 Jan;32(1):23-30. doi: 10.1016/j.healun.2012.09.026.
4
Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution.肺移植后淋巴细胞性细支气管炎与空气污染的日变化有关。
Am J Transplant. 2012 Jul;12(7):1831-8. doi: 10.1111/j.1600-6143.2012.04134.x. Epub 2012 Jun 8.
5
Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.探讨肺移植后弥漫性肺泡损伤的病理发现。
J Heart Lung Transplant. 2012 Apr;31(4):354-63. doi: 10.1016/j.healun.2011.12.015. Epub 2012 Feb 11.
6
CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.呼吸道病毒感染期间的 CXCR3 趋化因子配体可预测肺移植功能障碍。
Am J Transplant. 2012 Feb;12(2):477-84. doi: 10.1111/j.1600-6143.2011.03859.x. Epub 2011 Dec 7.
7
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant.肺移植后,γ干扰素依赖性趋化因子 CXCL9 和 CXCL10 的累积暴露与预后不良相关。
Am J Transplant. 2012 Feb;12(2):438-46. doi: 10.1111/j.1600-6143.2011.03857.x. Epub 2011 Dec 7.
8
The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.国际心肺移植学会登记处:第28份成人肺移植和心肺联合移植报告——2011年
J Heart Lung Transplant. 2011 Oct;30(10):1104-22. doi: 10.1016/j.healun.2011.08.004.
9
Survival determinants in lung transplant patients with chronic allograft dysfunction.慢性移植物功能障碍肺移植患者的生存决定因素。
Transplantation. 2011 Sep 27;92(6):703-8. doi: 10.1097/TP.0b013e31822bf790.
10
The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation.交通空气污染对肺移植后闭塞性细支气管炎综合征和死亡率的影响。
Thorax. 2011 Sep;66(9):748-54. doi: 10.1136/thx.2010.155192. Epub 2011 Mar 23.

CXCR3 配体与弥漫性肺泡损伤到慢性肺移植功能障碍的连续体有关。

CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.

机构信息

1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.

出版信息

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1117-25. doi: 10.1164/rccm.201305-0861OC.

DOI:10.1164/rccm.201305-0861OC
PMID:24063316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3863740/
Abstract

RATIONALE

After lung transplantation, insults to the allograft generally result in one of four histopathologic patterns of injury: (1) acute rejection, (2) lymphocytic bronchiolitis, (3) organizing pneumonia, and (4) diffuse alveolar damage (DAD). We hypothesized that DAD, the most severe form of acute lung injury, would lead to the highest risk of chronic lung allograft dysfunction (CLAD) and that a type I immune response would mediate this process.

OBJECTIVES

Determine whether DAD is associated with CLAD and explore the potential role of CXCR3/ligand biology.

METHODS

Transbronchial biopsies from all lung transplant recipients were reviewed. The association between the four injury patterns and subsequent outcomes were evaluated using proportional hazards models with time-dependent covariates. Bronchoalveolar lavage (BAL) concentrations of the CXCR3 ligands (CXCL9/MIG, CXCL10/IP10, and CXCL11/ITAC) were compared between allograft injury patterns and "healthy" biopsies using linear mixed-effects models. The effect of these chemokine alterations on CLAD risk was assessed using Cox models with serial BAL measurements as time-dependent covariates.

MEASUREMENTS AND MAIN RESULTS

There were 1,585 biopsies from 441 recipients with 62 episodes of DAD. An episode of DAD was associated with increased risk of CLAD (hazard ratio, 3.0; 95% confidence interval, 1.9-4.7) and death (hazard ratio, 2.3; 95% confidence interval, 1.7-3.0). There were marked elevations in BAL CXCR3 ligand concentrations during DAD. Furthermore, prolonged elevation of these chemokines in serial BAL fluid measurements predicted the development of CLAD.

CONCLUSIONS

DAD is associated with marked increases in the risk of CLAD and death after lung transplantation. This association may be mediated in part by an aberrant type I immune response involving CXCR3/ligands.

摘要

背景

肺移植后,同种异体移植物的损伤通常导致四种组织病理学损伤模式之一:(1)急性排斥反应,(2)淋巴细胞性细支气管炎,(3)机化性肺炎,和(4)弥漫性肺泡损伤(DAD)。我们假设 DAD,即最严重的急性肺损伤形式,会导致慢性肺移植物功能障碍(CLAD)的风险最高,并且 I 型免疫反应会介导这一过程。

目的

确定 DAD 是否与 CLAD 相关,并探讨 CXCR3/配体生物学的潜在作用。

方法

回顾所有肺移植受者的经支气管活检。使用具有时间依赖性协变量的比例风险模型评估四种损伤模式与随后结局之间的关联。使用线性混合效应模型比较同种异体损伤模式和“健康”活检之间的支气管肺泡灌洗液(BAL)中 CXCR3 配体(CXCL9/MIG、CXCL10/IP10 和 CXCL11/ITAC)的浓度。使用 Cox 模型,将连续 BAL 测量作为时间依赖性协变量,评估这些趋化因子改变对 CLAD 风险的影响。

测量和主要结果

来自 441 名受者的 1585 个活检中有 62 个 DAD 发作。DAD 发作与 CLAD(危险比,3.0;95%置信区间,1.9-4.7)和死亡(危险比,2.3;95%置信区间,1.7-3.0)的风险增加相关。在 DAD 期间,BAL CXCR3 配体浓度明显升高。此外,这些趋化因子在连续 BAL 液测量中的延长升高预测了 CLAD 的发展。

结论

DAD 与肺移植后 CLAD 和死亡风险的显著增加相关。这种关联部分可能是由涉及 CXCR3/配体的异常 I 型免疫反应介导的。